Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02229266
What this trial is testing

Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 1
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Large-scale testing (Phase 3)Study completedNCT02535663
What this trial is testing

Consumption of Dairy Yogurt Enhanced Immune Function

Who this might be right for
Healthy Volunteers
Yonsei University 120
Testing effectiveness (Phase 2)UnknownNCT01929499
What this trial is testing

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer

Who this might be right for
Colonic Neoplasms
Yanjuan Zhu 210
Early research (Phase 1)Study completedNCT02118285
What this trial is testing

Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Masonic Cancer Center, University of Minnesota 2
Testing effectiveness (Phase 2)Study completedNCT03618238
What this trial is testing

Anlotinib for Advanced and Refractory Natural Killer /T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 20
Early research (Phase 1)UnknownNCT02123836
What this trial is testing

Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome

Who this might be right for
Acute LeukaemiaMyelodysplastic Syndrome
National University Hospital, Singapore 20
Not applicableEnded earlyNCT01068470
What this trial is testing

Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy

Who this might be right for
MelanomaKidney Cancer
Loma Linda University 11
Testing effectiveness (Phase 2)Ended earlyNCT02520479
What this trial is testing

"Sandwich" Chemotherapy With Radiotherapy in Newly Diagnosed, Stage IE to IIE, ENKTL

Who this might be right for
Treatment Refusal
Sun Yat-sen University 12
Large-scale testing (Phase 3)UnknownNCT01481259
What this trial is testing

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 120
Early research (Phase 1)Looking for participantsNCT06044506
What this trial is testing

Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Dr Cipto Mangunkusumo General Hospital 3
Not applicableNot Yet RecruitingNCT07718308
What this trial is testing

CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAntibody-mediated Rejection
wujianyong 20
Testing effectiveness (Phase 2)Study completedNCT00328861
What this trial is testing

Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer

Who this might be right for
Metastatic MelanomaMetastatic Kidney Cancer
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)UnknownNCT03348033
What this trial is testing

Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Hospital de Clinicas de Porto Alegre 5
Not applicableLooking for participantsNCT07552233
What this trial is testing

NK Cell Therapy for Malignant Solid Brain Tumors

Who this might be right for
Malignant Solid Brain TumorsGlioblastoma (GBM)Glioblastoma Multiforme (GBM)+2 more
Peking University Third Hospital 27
Early research (Phase 1)UnknownNCT04309084
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasm, Plasma CellNeoplasms by Histologic Type+17 more
Celularity Incorporated 29
Early research (Phase 1)UnknownNCT03198923
What this trial is testing

Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Wenxiang Wang 30
Testing effectiveness (Phase 2)UnknownNCT02370017
What this trial is testing

Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment

Who this might be right for
Non-small Cell Lung Cancer
The Catholic University of Korea 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07230574
What this trial is testing

Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure

Who this might be right for
Abortion, MissedInfertility UnexplainedReproductive Disorder
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 159
Early research (Phase 1)UnknownNCT02399735
What this trial is testing

Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 18
Next Page